Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Elutia Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 17.2M | 17.4M | +168.6K (+1.0%) |
| Value | $43.6M | $34.4M | −$9.13M (−21.0%) |
New holders (2)
Institutions that held Elutia Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 14,012 | $27.7K | 0.00% |
| Raymond James Financial Inc | 1,100 | $2.18K | 0.00% |
Sold out (5)
Institutions that held Elutia Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 58,631 | $148.3K |
| Jefferies Financial Group Inc. | 25,600 | $64.8K |
| Omers Administration Corp | 10,892 | $27.6K |
| Prudential Financial Inc | 10,400 | $26.3K |
| American Capital Advisory, LLC | 100 | $253 |